Knowledge Distillery

Infections, including infection with SARS-CoV-2 (COVID-19), could alter the course of multiple sclerosis (MS). Previous studies assessing the effects…

Ninety-six patients with severe COVID-19 who survived intensive care unit (ICU) admission were enrolled in this prospective longitudinal cohort study.…

The authors studied blood-brain barrier (BBB) dysfunction in patients during acute SARS-Cov2 infection (76 inpatients and 25 pre-pandemic controls).…

This longitudinal study analysed digital cognitive tests’ data measuring executive functions (EF) and working memory (WM) from 3142 older adults (> 50…

Despite the high prevalence and major disability associated with fatigue and cognitive deficits after SARS-CoV-2 infection, little is known about…

This prospective cohort study within the United Kingdom COVID Symptom Study Biobank enrolled 3335 individuals with or without SARS-CoV-2 infection…

This study investigated the rate of breakthrough SARS-CoV-2 infection and clinical outcomes in a cohort of multiple sclerosis (MS) patients who were…

There are concerns on the safety of SARS-CoV-2 vaccination in patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory…

60 hospitalized patients with COVID-19 and acute neurological symptoms, 25 (42%) of them with encephalopathy and 14 (23%) with encephalitis, were…

Little is known about trajectories of recovery 12-months after hospitalisation for severe COVID. In this article the authors conducted a prospective,…

Several concerns exist on the immunogenicity of SARS-CoV-2 vaccines in multiple sclerosis (MS) subjects due to their immunomodulating disease…

Cognitive decline is a recognized manifestation of long COVID, even among patients who experienced mild disease. However, there is no evidence…